Writing

What is actually working at the intersection of life sciences commercialization and AI.

I write about life sciences commercialization from the operator's seat. AI is how the work is changing.

Practitioner-level. No trend-watching.

What I write about

Click a topic to switch
Where AI fits in how marketing teams actually run. Not theoretical. I embedded AI into 50% of Novartis marketing operations across 4 therapeutic areas and 10 brands. I write about what that taught me and what it means for teams building commercial capability today. Read this pillar →
Launch Playbook

What Launch Orchestration Actually Looks Like at Multi-Market Scale

Most teams running multi-market launch think the hard problem is localization. It is not. The hard part is orchestration: building an operating model eleven markets can actually run while still producing one brand. Six elements make it work, and most teams only build two.

4 min read · June 5, 2026
AI Inside Commercial Operations

AI Is Not a Tool. It Is an Operating Layer.

Most pharma teams are using AI. Fewer have made it part of how their commercial operation actually runs. That distinction is structural, not philosophical. Here is what it looked like when I built it at Novartis.

4 min read · May 22, 2026
AI Inside Commercial Operations

Commercial Execution Is What Turns Science Into Investment

Innovation in healthcare does not begin with a scientific breakthrough. It begins with trust. And trust is built through commercial

1 min read · May 16, 2026
Launch Playbook

The Pre-Launch Work Nobody Talks About

Most people see the final campaign, the brand on pharmacy shelves, the press release. The launch is the visible part.

1 min read · May 16, 2026
AI Inside Commercial Operations

A Unified Commercial Story Outperforms Any Channel Mix

Most pharma and MedTech teams have invested in omnichannel. They have the channels. What they often do not have is

1 min read · May 16, 2026

Not on a schedule. Only when I have something worth reading.